INSMED INC Marketable Securities
INSMED INC (INSM) had Marketable Securities of $298.80 million as of 2023-09-30, per its 10-Q filed 2023-10-26.
Discontinued › Balance Sheet › Assets
us-gaap:MarketableSecurities · last filed 2023-10-26
- 2023-09-30: Marketable Securities $298.80M.
- 2023-06-30: Marketable Securities $304.90M.
- 2023-03-31: Marketable Securities $29.80M.
- 2022-09-30: Marketable Securities $98.70M.
| Period end | Marketable Securities |
|---|---|
| 2023-09-30 | $298.80M 10-Q · filed 2023-10-26 |
| 2023-06-30 | $304.90M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $29.80M 10-Q · filed 2023-05-04 |
| 2022-09-30 | $98.70M 10-Q · filed 2022-10-27 |
| 2022-06-30 | $148.60M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $149.00M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $50.00M 10-Q · filed 2022-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |